Published in
Royal Society of Chemistry, RSC Medicinal Chemistry, 9(12), p. 1525-1539, 2021
DOI: 10.1039/d1md00124h
Links
Tools
Identification of a Zika NS2B epitope as a biomarker for severe clinical phenotypes
Journal article published in 2021 by
Felix F. Loeffler 
,
Isabelle F. T. Viana ,
Nico Fischer,
Danilo F. Coêlho ,
Carolina S. Silva ,
Antônio F. Purificação,
Catarina M. C. S. Araújo,
Bruno H. S. Leite,
Ricardo Durães-Carvalho ,
Tereza Magalhães,
Clarice N. L. Morais,
Marli T. Cordeiro,
Roberto D. Lins ,
Ernesto T. A. Marques ,
Thomas Jaenisch
,
Isabelle F. T. Viana ,
Nico Fischer,
Danilo F. Coêlho ,
Carolina S. Silva ,
Antônio F. Purificação,
Catarina M. C. S. Araújo,
Bruno H. S. Leite,
Ricardo Durães-Carvalho ,
Tereza Magalhães,
Clarice N. L. Morais,
Marli T. Cordeiro,
Roberto D. Lins ,
Ernesto T. A. Marques ,
Thomas Jaenisch
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
The identification of specific biomarkers for Zika infection and its clinical complications is fundamental to mitigate the infection spread, which has been associated with a broad range of neurological sequelae.